ArticlePrzeglad gastroenterologiczny2026

Multicentre retrospective real-world evidence study evaluating the effectiveness and safety of mirikizumab in patients with moderately to severely active ulcerative colitis.

Łukasz Lamparski et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.